Number and percentage of patients with specific visit reports/notes during the first 12 months after initiation of rhythm control therapy
| . | ECG (n/%) . | Cardiac monitor (n/%) . | ECG or cardiac monitor (n/%) . | Clinical note (n/%) . | Total (n/%) . |
|---|---|---|---|---|---|
| Ablation | |||||
| site 1 (n = 366) | 307 (83.9%) | 274 (74.9%) | 346 (94.5%) | 365 (99.7%) | 365 (99.7%) |
| site 2 (n = 621) | 579 (93.2%) | 543 (87.4%) | 614 (98.9%) | 621 (100%) | 621 (100%) |
| Antiarrhythmic medication | |||||
| site 1 (n = 8979) | 6898 (76.8%) | 2487 (27.7%) | 7111 (79.2%) | 8343 (92.9%) | 8360 (93.1%) |
| site 2 (n = 10 862) | 8244 (75.9%) | 2826 (26.0%) | 8611 (79.3%) | 9814 (90.4%) | 9921 (91.03%) |
| Cardioversion | |||||
| site 1 (n = 3264) | 2761 (84.6%) | 995 (30.5%) | 2795 (85.6%) | 3191 (97.8%) | 3193 (97.8%) |
| site 2 (n = 4564) | 4098 (89.8%) | 1298 (28.4%) | 4178 (91.5%) | 4465 (97.8%) | 4516 (98.9%) |
| Pacemaker combined with nodal ablation | |||||
| site 1 (n = 63) | 44 (69.8%) | 35 (55.6%) | 49 (77.8%) | 62 (98.4%) | 62 (98.4%) |
| site 2 (n = 13) | 8 (61.5%) | 1 (7.7%) | 8 (61.5%) | 13 (100%) | 13 (100%) |
| . | ECG (n/%) . | Cardiac monitor (n/%) . | ECG or cardiac monitor (n/%) . | Clinical note (n/%) . | Total (n/%) . |
|---|---|---|---|---|---|
| Ablation | |||||
| site 1 (n = 366) | 307 (83.9%) | 274 (74.9%) | 346 (94.5%) | 365 (99.7%) | 365 (99.7%) |
| site 2 (n = 621) | 579 (93.2%) | 543 (87.4%) | 614 (98.9%) | 621 (100%) | 621 (100%) |
| Antiarrhythmic medication | |||||
| site 1 (n = 8979) | 6898 (76.8%) | 2487 (27.7%) | 7111 (79.2%) | 8343 (92.9%) | 8360 (93.1%) |
| site 2 (n = 10 862) | 8244 (75.9%) | 2826 (26.0%) | 8611 (79.3%) | 9814 (90.4%) | 9921 (91.03%) |
| Cardioversion | |||||
| site 1 (n = 3264) | 2761 (84.6%) | 995 (30.5%) | 2795 (85.6%) | 3191 (97.8%) | 3193 (97.8%) |
| site 2 (n = 4564) | 4098 (89.8%) | 1298 (28.4%) | 4178 (91.5%) | 4465 (97.8%) | 4516 (98.9%) |
| Pacemaker combined with nodal ablation | |||||
| site 1 (n = 63) | 44 (69.8%) | 35 (55.6%) | 49 (77.8%) | 62 (98.4%) | 62 (98.4%) |
| site 2 (n = 13) | 8 (61.5%) | 1 (7.7%) | 8 (61.5%) | 13 (100%) | 13 (100%) |
ECG = electrocardiogram.
Number and percentage of patients with specific visit reports/notes during the first 12 months after initiation of rhythm control therapy
| . | ECG (n/%) . | Cardiac monitor (n/%) . | ECG or cardiac monitor (n/%) . | Clinical note (n/%) . | Total (n/%) . |
|---|---|---|---|---|---|
| Ablation | |||||
| site 1 (n = 366) | 307 (83.9%) | 274 (74.9%) | 346 (94.5%) | 365 (99.7%) | 365 (99.7%) |
| site 2 (n = 621) | 579 (93.2%) | 543 (87.4%) | 614 (98.9%) | 621 (100%) | 621 (100%) |
| Antiarrhythmic medication | |||||
| site 1 (n = 8979) | 6898 (76.8%) | 2487 (27.7%) | 7111 (79.2%) | 8343 (92.9%) | 8360 (93.1%) |
| site 2 (n = 10 862) | 8244 (75.9%) | 2826 (26.0%) | 8611 (79.3%) | 9814 (90.4%) | 9921 (91.03%) |
| Cardioversion | |||||
| site 1 (n = 3264) | 2761 (84.6%) | 995 (30.5%) | 2795 (85.6%) | 3191 (97.8%) | 3193 (97.8%) |
| site 2 (n = 4564) | 4098 (89.8%) | 1298 (28.4%) | 4178 (91.5%) | 4465 (97.8%) | 4516 (98.9%) |
| Pacemaker combined with nodal ablation | |||||
| site 1 (n = 63) | 44 (69.8%) | 35 (55.6%) | 49 (77.8%) | 62 (98.4%) | 62 (98.4%) |
| site 2 (n = 13) | 8 (61.5%) | 1 (7.7%) | 8 (61.5%) | 13 (100%) | 13 (100%) |
| . | ECG (n/%) . | Cardiac monitor (n/%) . | ECG or cardiac monitor (n/%) . | Clinical note (n/%) . | Total (n/%) . |
|---|---|---|---|---|---|
| Ablation | |||||
| site 1 (n = 366) | 307 (83.9%) | 274 (74.9%) | 346 (94.5%) | 365 (99.7%) | 365 (99.7%) |
| site 2 (n = 621) | 579 (93.2%) | 543 (87.4%) | 614 (98.9%) | 621 (100%) | 621 (100%) |
| Antiarrhythmic medication | |||||
| site 1 (n = 8979) | 6898 (76.8%) | 2487 (27.7%) | 7111 (79.2%) | 8343 (92.9%) | 8360 (93.1%) |
| site 2 (n = 10 862) | 8244 (75.9%) | 2826 (26.0%) | 8611 (79.3%) | 9814 (90.4%) | 9921 (91.03%) |
| Cardioversion | |||||
| site 1 (n = 3264) | 2761 (84.6%) | 995 (30.5%) | 2795 (85.6%) | 3191 (97.8%) | 3193 (97.8%) |
| site 2 (n = 4564) | 4098 (89.8%) | 1298 (28.4%) | 4178 (91.5%) | 4465 (97.8%) | 4516 (98.9%) |
| Pacemaker combined with nodal ablation | |||||
| site 1 (n = 63) | 44 (69.8%) | 35 (55.6%) | 49 (77.8%) | 62 (98.4%) | 62 (98.4%) |
| site 2 (n = 13) | 8 (61.5%) | 1 (7.7%) | 8 (61.5%) | 13 (100%) | 13 (100%) |
ECG = electrocardiogram.
This PDF is available to Subscribers Only
View Article Abstract & Purchase OptionsFor full access to this pdf, sign in to an existing account, or purchase an annual subscription.
